Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2955 USD | -1.17% | -8.43% | -86.06% |
May. 10 | ENDRA Life Sciences Inc. Provides Earnings Guidance for the Quarter Ended March 31, 2024 | CI |
Mar. 28 | Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.06% | 3.3M | |
+23.92% | 44.96B | |
+0.42% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.70% | 26.08B | |
-21.16% | 19.03B | |
+6.78% | 12.75B | |
+29.23% | 12.06B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- NDRA Stock
- News ENDRA Life Sciences Inc.
- Endra Life Sciences Says de Novo Application for TAEUS Monitor Due in 'Coming Weeks'